593 related articles for article (PubMed ID: 21209124)
21. Circumferential and focal ablation of Barrett's esophagus containing dysplasia.
Sharma VK; Jae Kim H; Das A; Wells CD; Nguyen CC; Fleischer DE
Am J Gastroenterol; 2009 Feb; 104(2):310-7. PubMed ID: 19174783
[TBL] [Abstract][Full Text] [Related]
22. Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett's esophagus with early neoplasia.
Barret M; Belghazi K; Weusten BL; Bergman JJ; Pouw RE
Gastrointest Endosc; 2016 Jul; 84(1):29-36. PubMed ID: 26769410
[TBL] [Abstract][Full Text] [Related]
23. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
Kim MP; Brown KN; Schwartz MR; Blackmon SH
Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
25. [Endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) in neoplastic Barrett's esophagus or Barrett early cancer is also economically superior to sole radical endoscopic resection].
Wilke M; Rathmayer M; Schenker M; Schepp W
Z Gastroenterol; 2016 May; 54(5):416-20. PubMed ID: 27171331
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency Ablation in Patients with Barrett's Esophagus- related Neoplasia - Long-Term Outcomes in the Czech National Database.
Krajciova J; Janicko M; Falt P; Gregar J; Suchanek S; Ngo O; Kollar M; Urban O; Prochazka V; Zavoral M; Spicak J; Martinek J
J Gastrointestin Liver Dis; 2019 Jun; 28():149-155. PubMed ID: 31204400
[TBL] [Abstract][Full Text] [Related]
27. Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.
Caillol F; Godat S; Autret A; Bories E; Pesenti C; Ratone JP; Poizat F; Guiramand J; Delpero JR; Giovannini M
Surg Endosc; 2016 Dec; 30(12):5410-5418. PubMed ID: 27129553
[TBL] [Abstract][Full Text] [Related]
28. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
[TBL] [Abstract][Full Text] [Related]
29. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.
Phoa KN; Pouw RE; van Vilsteren FGI; Sondermeijer CMT; Ten Kate FJW; Visser M; Meijer SL; van Berge Henegouwen MI; Weusten BLAM; Schoon EJ; Mallant-Hent RC; Bergman JJGHM
Gastroenterology; 2013 Jul; 145(1):96-104. PubMed ID: 23542068
[TBL] [Abstract][Full Text] [Related]
30. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
[TBL] [Abstract][Full Text] [Related]
31. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial.
Sharma P; Hawes RH; Bansal A; Gupta N; Curvers W; Rastogi A; Singh M; Hall M; Mathur SC; Wani SB; Hoffman B; Gaddam S; Fockens P; Bergman JJ
Gut; 2013 Jan; 62(1):15-21. PubMed ID: 22315471
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
33. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
[TBL] [Abstract][Full Text] [Related]
34. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study.
Peters FP; Kara MA; Rosmolen WD; ten Kate FJ; Krishnadath KK; van Lanschot JJ; Fockens P; Bergman JJ
Am J Gastroenterol; 2006 Jul; 101(7):1449-57. PubMed ID: 16863545
[TBL] [Abstract][Full Text] [Related]
35. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
36. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
Pech O; Ell C
Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
[TBL] [Abstract][Full Text] [Related]
37. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
38. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
[TBL] [Abstract][Full Text] [Related]
39. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.
Johnson CS; Louie BE; Wille A; Dunst CM; Worrell SG; DeMeester SR; Reynolds J; Dixon J; Lipham JC; Lada M; Peters JH; Watson TJ; Farivar AS; Aye RW
J Gastrointest Surg; 2015 May; 19(5):799-805. PubMed ID: 25740341
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett's esophagus-related neoplasia: a systematic review and pooled analysis.
Desai M; Saligram S; Gupta N; Vennalaganti P; Bansal A; Choudhary A; Vennelaganti S; He J; Titi M; Maselli R; Qumseya B; Olyaee M; Waxman I; Repici A; Hassan C; Sharma P
Gastrointest Endosc; 2017 Mar; 85(3):482-495.e4. PubMed ID: 27670227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
